acebutolol has been researched along with ferrous sulfate in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 12 (50.00) | 24.3611 |
| 2020's | 7 (29.17) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, JB; Mangione, A; Martens, MG; Seid, MH; Van Wyck, DB | 1 |
| Bejenariu, C; Breymann, C; Gliga, F; Strizhova, N | 1 |
| D'Haens, G; Dudar, LV; Garcia, LC; Gasche, C; Karnafel, W; Kulnigg, S; Sambuelli, AM; Simanenkov, V; Stoinov, S | 1 |
| Baker, JB; Banach, W; Derman, RJ; Goldberg, C; Rogers, R; Seid, MH | 1 |
| Goodnough, LT; Hadley, PE; Jehle, JA; Mangione, A; Morrison, J; Van Wyck, DB | 1 |
| Canclini, C; Funk, F; Geisser, P; Neiser, S; Ryle, P | 1 |
| Bregman, DB; Goodnough, LT; He, A; Koch, TA; Morris, D | 1 |
| Bock, A; Carrera, F; Cushway, T; Eckardt, KU; Gaillard, C; Macdougall, IC; Roger, SD; Roubert, B; Van Wyck, D | 1 |
| Gasche, C; Iqbal, T; Kulnigg-Dabsch, S; Sharma, N; Stein, J; Vel, S | 1 |
| Macdougall, IC | 1 |
| Bernard, R; Breymann, C; Dudenhausen, J; Mezzacasa, A; Milman, N | 1 |
| Acheson, AG; Brookes, MJ; Keeler, BD; Ng, O; Padmanabhan, H; Simpson, JA | 1 |
| Eichner, D; Garvican-Lewis, LA; Gore, CJ; Govus, AD; Hughes, D; Jung, G; Lovell, G; Nemeth, E; Peeling, P; Vuong, VL | 1 |
| Biboulet, P; Bringuier, S; Capdevila, X; Dangelser, G; Loupec, T; Maissiat, G; Pencole, M; Smilevitch, P; Thuile, C | 1 |
| Cho, YK; Jun, JK; Kim, A; Kim, MY; Kim, YJ; Lee, JJ; Lee, KY; Lee, Y; Shim, JY; Shin, JC; Song, TB | 1 |
| García-Erce, JA; Lorente Aznar, T; Rivilla Marugán, L | 1 |
| Allen, JC; Chuang, A; Dennis, A; Falloon, P; Gray, Z; Hanna, F; Hyppa, A; Khalafallah, AA; Kwok, C; Mathew, R; Pavlov, T; Wilson, E; Yan, C | 1 |
| Anker, SD; Ebner, N; Evertz, R; Ponikowski, P; von Haehling, S | 1 |
| DelRosso, LM; Ferri, R; Picchietti, DL | 1 |
| Abdulla, S; Asilia, P; Daubenberger, C; Glass, TR; Issa, A; Kuemmerle, A; Lweno, O; Meyer-Monard, S; Mswata, S; Mwebi, KD; Schmidlin, S; Simon, B; Tanner, M; Vanobberghen, F | 1 |
| Allinovi, M; Bagalà, A; Ballo, P; Bellelli, S; Cirillo, L; Dallari, LA; Dattolo, PC; Di Marcantonio, E; Ferro, G; Somma, C | 1 |
| Amezcua-Prieto, C; Daru, J; Godolphin, PJ; Khan, KS; Nicolaides, M; Robinson, S; Rogozińska, E; Saborido, CM; Thangaratinam, S; Wang, R; Zamora, J | 1 |
| Acheson, AG; Al-Hassi, HO; Brookes, MJ; Evstatiev, R; Gasche, C; Jambrich, M; Keeler, B; Khare, V; Mangalika, M; Ng, O; Phipps, O; Worton, N | 1 |
| Arjona Berral, JE; Baquero Úbeda, JL; Casellas Caro, M; Cerezales, M; Cuervo, J; García-Erce, JA; Gredilla Díaz, E; Hidalgo, MJC; Jiménez Merino, S; Martín Bayón, I; Muñoz Solano, A; Nicolás Picó, J; Ruano Encinar, M; Torras Boatella, MG | 1 |
5 review(s) available for acebutolol and ferrous sulfate
| Article | Year |
|---|---|
The new generation of intravenous iron: chemistry, pharmacology, and toxicology of ferric carboxymaltose.
Topics: Animals; Escherichia coli; Ferric Compounds; Ferrous Compounds; Humans; Infusions, Intravenous; Injections; Iron; Kinetics; Liver; Maltose; Mice; Mutagens; Safety; Salmonella typhimurium; Thermodynamics | 2010 |
Iron Treatment Strategies in Nondialysis CKD.
Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Glucaric Acid; Hematinics; Hemoglobins; Humans; Iron Compounds; Maltose; Renal Insufficiency, Chronic; Severity of Illness Index; Transferrin | 2016 |
Iron Deficiency in Heart Failure: An Overview.
Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Cardiovascular Diseases; Comorbidity; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Heart Failure; Hematinics; Hemoglobins; Hospitalization; Humans; Maltose; Oxygen Consumption; Prevalence; Quality of Life; Stroke Volume; Transferrin; Walk Test | 2019 |
Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis.
Topics: Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferritins; Ferrous Compounds; Hemoglobins; Humans; Maltose; Nausea; Pregnancy | 2021 |
Applying reflective multicriteria decision analysis to understand the value of therapeutic alternatives in the management of gestational and peripartum anaemia in Spain.
Topics: Anemia, Iron-Deficiency; Decision Support Techniques; Female; Ferric Compounds; Ferrous Compounds; Humans; Maltose; Pregnancy; Pregnancy Complications, Hematologic; Risk Assessment; Spain; Stakeholder Participation | 2022 |
12 trial(s) available for acebutolol and ferrous sulfate
| Article | Year |
|---|---|
Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial.
Topics: Administration, Oral; Adult; Anemia; Dietary Supplements; Drug Administration Schedule; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Maltose; Mexico; Postpartum Period; Pregnancy; United States | 2007 |
Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia.
Topics: Administration, Oral; Adolescent; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Hemoglobins; Humans; Infusions, Intravenous; Iron; Iron Deficiencies; Maltose; Postpartum Period; Time Factors; Treatment Outcome | 2008 |
A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.
Topics: Administration, Oral; Adult; Aged; Anemia, Iron-Deficiency; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Germany; Hemoglobinometry; Humans; Infusions, Intravenous; Male; Maltose; Middle Aged | 2008 |
Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial.
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Humans; Injections; Maltose; Puerperal Disorders; Treatment Outcome | 2008 |
Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Calcium; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Hemoglobins; Humans; Injections, Intravenous; Maltose; Middle Aged; Phosphates; Potassium; Quality of Life; Treatment Outcome; Uterine Hemorrhage | 2009 |
Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia.
Topics: Adult; Anemia, Iron-Deficiency; Antimicrobial Cationic Peptides; Biomarkers; Dietary Supplements; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Hemoglobins; Hepcidins; Humans; Injections, Intravenous; Iron, Dietary; Male; Maltose; Predictive Value of Tests; Sensitivity and Specificity; Transferrin | 2013 |
The FIND-CKD study--a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale.
Topics: Administration, Oral; Adult; Aged; Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Follow-Up Studies; Glomerular Filtration Rate; Hemoglobins; Humans; Injections, Intravenous; Iron; Male; Maltose; Middle Aged; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome | 2014 |
Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP).
Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferrous Compounds; Humans; Infant, Newborn; Maltose; Pregnancy; Pregnancy Complications, Hematologic; Quality of Life; Treatment Outcome | 2017 |
Randomized clinical trial of preoperative oral versus intravenous iron in anaemic patients with colorectal cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Colorectal Neoplasms; Elective Surgical Procedures; Erythrocyte Transfusion; Female; Ferric Compounds; Ferrous Compounds; Follow-Up Studies; Hematinics; Humans; Injections, Intravenous; Male; Maltose; Middle Aged; Postoperative Complications; Preoperative Care; Prospective Studies; Treatment Outcome | 2017 |
Preoperative Epoetin-α with Intravenous or Oral Iron for Major Orthopedic Surgery: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Drug Therapy, Combination; Epoetin Alfa; Female; Ferric Compounds; Ferrous Compounds; Hematinics; Humans; Iron; Male; Maltose; Middle Aged; Orthopedic Procedures; Postoperative Complications; Preoperative Care; Prospective Studies; Single-Blind Method | 2018 |
A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy.
Topics: Administration, Oral; Adolescent; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferrous Compounds; Humans; Infusions, Intravenous; Maltose; Middle Aged; Pregnancy; Prospective Studies; Young Adult | 2018 |
Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial.
Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferrous Compounds; Folic Acid; Hemoglobins; Humans; Iron; Maltose; Postnatal Care; Postpartum Period; Pregnancy; Tanzania; Treatment Outcome; Young Adult | 2021 |
7 other study(ies) available for acebutolol and ferrous sulfate
| Article | Year |
|---|---|
Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemia.
Topics: Administration, Intravenous; Administration, Oral; Anemia, Iron-Deficiency; Biomarkers; C-Reactive Protein; Clinical Trials, Phase III as Topic; Colitis, Ulcerative; Crohn Disease; Ferric Compounds; Ferrous Compounds; Hematinics; Hemoglobins; Humans; Inflammation Mediators; Interleukin-6; Maltose; Randomized Controlled Trials as Topic; Retrospective Studies; Time Factors; Treatment Outcome | 2015 |
Intravenous Iron Does Not Augment the Hemoglobin Mass Response to Simulated Hypoxia.
Topics: Adaptation, Physiological; Administration, Intravenous; Administration, Oral; Adult; Altitude; Dietary Supplements; Erythropoietin; Female; Ferric Compounds; Ferrous Compounds; Hemoglobins; Humans; Hypoxia; Male; Maltose; Physical Conditioning, Human; Physical Endurance; Young Adult | 2018 |
Efficacy and safety of ferric carboxymaltose versus ferrous sulfate for iron deficiency anemia during pregnancy: subgroup analysis of Korean women.
Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferrous Compounds; Hemoglobins; Humans; Maltose; Pregnancy; Pregnancy Complications, Hematologic; Republic of Korea; Young Adult | 2018 |
Effectiveness of outpatient treatment with intravenous iron in selected primary Care patients.
Topics: Administration, Intravenous; Adult; Aged, 80 and over; Anemia, Iron-Deficiency; Female; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Hematinics; Humans; Male; Maltose; Middle Aged | 2020 |
Comparison between oral ferrous sulfate and intravenous ferric carboxymaltose in children with restless sleep disorder.
Topics: Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Ferric Compounds; Ferrous Compounds; Humans; Maltose; Pilot Projects; Retrospective Studies; Sleep Wake Disorders | 2021 |
Ferric carboxymaltose vs. ferrous sulfate for the treatment of anemia in advanced chronic kidney disease: an observational retrospective study and cost analysis.
Topics: Aged; Anemia; Costs and Cost Analysis; Darbepoetin alfa; Ferric Compounds; Ferrous Compounds; Hematologic Tests; Hemoglobins; Humans; Iron; Maltose; Renal Insufficiency, Chronic; Retrospective Studies; Time Factors; Treatment Outcome | 2021 |
Intravenous iron is non-inferior to oral iron regarding cell growth and iron metabolism in colorectal cancer associated with iron-deficiency anaemia.
Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Cell Proliferation; Colorectal Neoplasms; Female; Ferric Compounds; Ferrous Compounds; Humans; Iron; Male; Maltose; Middle Aged | 2021 |